These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 19027322

  • 1. Cytokine profiles of HIV patients with pulmonary tuberculosis resulting from adjunct immunotherapy with herbal phytoconcentrates Dzherelo and Anemin.
    Nikolaeva LG, Maystat TV, Pylypchuk VS, Volyanskii YL, Frolov VM, Kutsyna GA.
    Cytokine; 2008 Dec; 44(3):392-6. PubMed ID: 19027322
    [Abstract] [Full Text] [Related]

  • 2. Effect of oral immunomodulator Dzherelo in TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOTS.
    Nikolaeva LG, Maystat TV, Pylypchuk VS, Volyanskii YL, Masyuk LA, Kutsyna GA.
    Int Immunopharmacol; 2008 Jun; 8(6):845-51. PubMed ID: 18442788
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cytokine profile in human immunodeficiency virus positive patients with and without tuberculosis.
    Agarwal SK, Singh A, Anuradha S, Singh NP, Sokhi J, Baveja UK.
    J Assoc Physicians India; 2001 Aug; 49():799-802. PubMed ID: 11837467
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of efficacy of tuberculosis drugs with Immunoxel (Dzherelo) in HIV-infected patients with active pulmonary tuberculosis.
    Arjanova OV, Prihoda ND, Yurchenko LV, Sokolenko NI, Vihrova LA, Pylypchuk VS, Frolov VM, Kutsyna GA.
    Immunotherapy; 2009 Jul; 1(4):549-56. PubMed ID: 20635986
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic accuracy of cytokine levels (TNF-alpha, IL-2 and IFN-gamma) in bronchoalveolar lavage fluid of smear-negative pulmonary tuberculosis patients.
    Küpeli E, Karnak D, Beder S, Kayacan O, Tutkak H.
    Respiration; 2008 Jul; 75(1):73-8. PubMed ID: 17975298
    [Abstract] [Full Text] [Related]

  • 7. Dzherelo (Immunoxel) as adjunctive therapy to standard antituberculosis treatment in patients with pulmonary tuberculosis: a systematic review and meta-analysis of clinical trials.
    Kitenge M, Phiri B, Pheeha SM, Ogunrombi M, Nyasulu PS.
    Syst Rev; 2021 May 26; 10(1):157. PubMed ID: 34039420
    [Abstract] [Full Text] [Related]

  • 8. Post-treatment changes of six cytokines in active pulmonary tuberculosis: differences between patients with stable or increased fibrosis.
    Ameglio F, Casarini M, Capoluongo E, Mattia P, Puglisi G, Giosuè S.
    Int J Tuberc Lung Dis; 2005 Jan 26; 9(1):98-104. PubMed ID: 15675558
    [Abstract] [Full Text] [Related]

  • 9. The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis.
    Morosini M, Meloni F, Marone Bianco A, Paschetto E, Uccelli M, Pozzi E, Fietta A.
    Int J Tuberc Lung Dis; 2003 Oct 26; 7(10):994-1000. PubMed ID: 14552571
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cytokine expression during syphilis infection in HIV-1-infected individuals.
    Knudsen A, Benfield T, Kofoed K.
    Sex Transm Dis; 2009 May 26; 36(5):300-4. PubMed ID: 19265730
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Kinetics of sedimentation rate, viral load and TNF-alpha in relation to HIV co-infection in tuberculosis.
    Schön T, Wolday D, Elias D, Melese E, Moges F, Tessema T, Stendahl O, Sundqvist T, Britton S.
    Trans R Soc Trop Med Hyg; 2006 May 26; 100(5):483-8. PubMed ID: 16242741
    [Abstract] [Full Text] [Related]

  • 14. Clinical validation of sublingual formulations of Immunoxel (Dzherelo) as an adjuvant immunotherapy in treatment of TB patients.
    Efremenko YV, Arjanova OV, Prihoda ND, Yurchenko LV, Sokolenko NI, Mospan IV, Pylypchuk VS, Rowe J, Jirathitikal V, Bourinbaiar AS, Kutsyna GA.
    Immunotherapy; 2012 Mar 26; 4(3):273-82. PubMed ID: 22401633
    [Abstract] [Full Text] [Related]

  • 15. Serological markers of pulmonary tuberculosis and of response to anti-tuberculosis treatment in a patient population in Guinea.
    Azzurri A, Kanaujia GV, Sow OY, Bah B, Diallo A, Del Prete G, Gennaro ML.
    Int J Immunopathol Pharmacol; 2006 Mar 26; 19(1):199-208. PubMed ID: 16569358
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis.
    Batbold U, Butov DO, Kutsyna GA, Damdinpurev N, Grinishina EA, Mijiddorj O, Kovolev ME, Baasanjav K, Butova TS, Sandagdorj M, Batbold O, Tseveendorj A, Chunt E, Zaitzeva SI, Stepanenko HL, Makeeva NI, Mospan IV, Pylypchuk VS, Rowe JL, Nyasulu P, Jirathitikal V, Bain AI, Tarakanovskaya MG, Bourinbaiar AS.
    Immunotherapy; 2017 Jan 26; 9(1):13-24. PubMed ID: 27868466
    [Abstract] [Full Text] [Related]

  • 18. Changes in CD4+ T-cells and HIV RNA resulting from combination of anti-TB therapy with Dzherelo in TB/HIV dually infected patients.
    Nikolaeva LG, Maystat TV, Masyuk LA, Pylypchuk VS, Volyanskii YL, Kutsyna GA.
    Drug Des Devel Ther; 2009 Feb 06; 2():87-93. PubMed ID: 19920896
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.